Health & Conditions

94 articles

All articles
Health & Conditions

GLP-1 for Perimenopause: Weight Gain & Insulin (2026)

GLP-1 for perimenopause is used to treat the weight gain, rising insulin resistance, and belly fat that begin during the transition years — often while you are still having periods — not perimenopause itself. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) can help, but protein and strength training are essential because perimenopause is when lean-muscle loss accelerates.

5 min read
Health & Conditions

GLP-1 Period Changes, Fatigue & Hot Flashes (2026)

On a GLP-1 (semaglutide — Ozempic, Wegovy; or tirzepatide — Mounjaro, Zepbound), period changes and hot flashes are mostly indirect — driven by weight loss, hormone shifts, and midlife menopause overlap, not a direct drug action — while fatigue is a recognized side effect tied to eating less, dehydration, and low blood sugar. Track them; verify causes with your clinician.

6 min read
Health & Conditions

GLP-1 Postpartum: Breastfeeding Safety & Weight (2026)

GLP-1s are not recommended while breastfeeding. The FDA Wegovy (semaglutide) label states breastfeeding is not recommended during treatment, and clinical guidance advises avoiding tirzepatide while nursing. GLP-1s must also be stopped in pregnancy. Any use for postpartum weight loss is an individual decision to make with your OB-GYN — usually only once you are no longer breastfeeding.

4 min read
Health & Conditions

GLP-1 for Menopause: Weight Gain, Belly Fat & Muscle (2026)

GLP-1 for menopause is used to treat the weight gain and visceral belly fat that often accompany the menopause transition — not menopause itself. Drugs like semaglutide (Ozempic, Wegovy) can reduce weight and abdominal fat, but a portion of the loss is muscle, so protein and strength training are essential to protect midlife muscle and bone.

5 min read
Health & Conditions

GLP-1 for PCOS: Semaglutide, Weight & Ovulation (2026)

GLP-1 medications for PCOS are used off-label — they are not FDA-approved for polycystic ovary syndrome itself. By driving weight loss and improving insulin resistance, drugs like semaglutide (Ozempic, Wegovy) can help restore ovulation and more regular cycles in some women, but they require medical supervision and are not for use in pregnancy.

6 min read

Ready for Smarter Weight Loss?

Everything you need to lose weight, preserve muscle, and build healthier habits—all in one AI-powered app.

Download on the App StoreGet it on Google Play

Free to download. In-app purchases may apply.